Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Positron Emission Tomography in Determining Stage of Esophageal Cancer

ClinicalTrials.gov ID: NCT00004867

Public ClinicalTrials.gov record NCT00004867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer. PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer.

Study identification

NCT ID
NCT00004867
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
235 participants

Conditions and interventions

Interventions

Procedure · Radiation · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1999 (Type not available)
Primary completion
Jul 2005 (Actual)
Completion
Jan 2009 (Actual)
Last update posted
Jan 24, 2017

1999 – 2009

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama 35294-3300 —
Mobile Infirmary Medical Center Mobile Alabama 36640-0460 —
University of South Alabama Cancer Research Institute Mobile Alabama 36688 —
Jonsson Comprehensive Cancer Center at UCLA Los Angeles California 90095-1781 —
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange California 92868 —
UCSF Comprehensive Cancer Center San Francisco California 94115 —
Stanford Cancer Center at Stanford University Medical Center Stanford California 94305-5407 —
University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora Colorado 80010 —
Morton Plant Hospital Clearwater Florida 33756 —
Indiana University Cancer Center Indianapolis Indiana 46202 —
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201 —
Cancer Center at Greater Baltimore Medical Center Baltimore Maryland 21204 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
William Beaumont Hospital - Royal Oak Royal Oak Michigan 48073 —
Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri 63110 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44302 —
Bethesda North Hospital Cincinnati Ohio 45242 —
Tri-Health Good Samaritan Hospital Cincinnati Ohio 90027 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus Ohio 43210-1240 —
Providence Cancer Center at Providence Portland Medical Center Portland Oregon 97213-2967 —
Westmoreland Regional Hospital Greensburg Pennsylvania 15601-2282 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212-4772 —
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224 —
St. Clair Memorial Hospital Pittsburgh Pennsylvania 15243-1899 —
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425 —
University of Tennessee, Memphis Memphis Tennessee 38163 —
Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus Nashville Tennessee 37212 —
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville Tennessee 37232-6838 —
Baylor University Medical Center Dallas Texas 75246 —
LDS Hospital Salt Lake City Utah 84143 —
Massey Cancer Center at Virginia Commonwealth University Richmond Virginia 23298-0037 —
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2017 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00004867 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →